Cargando…
Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649353/ http://dx.doi.org/10.1186/2051-1426-3-S2-P366 |
| _version_ | 1782401339826896896 |
|---|---|
| author | Mace, Thomas Shakya, Reena Pitarresi, Jason Loftus, Shannon Swanson, Benjamin Young, Gregory Zhong, Xioling Zimmers, Teresa Ostrowski, Michael Ludwig, Thomas Bloomston, Mark Bekaii-Saab, Tanios Lesinski, Gregory |
| author_facet | Mace, Thomas Shakya, Reena Pitarresi, Jason Loftus, Shannon Swanson, Benjamin Young, Gregory Zhong, Xioling Zimmers, Teresa Ostrowski, Michael Ludwig, Thomas Bloomston, Mark Bekaii-Saab, Tanios Lesinski, Gregory |
| author_sort | Mace, Thomas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4649353 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-46493532015-11-24 Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer Mace, Thomas Shakya, Reena Pitarresi, Jason Loftus, Shannon Swanson, Benjamin Young, Gregory Zhong, Xioling Zimmers, Teresa Ostrowski, Michael Ludwig, Thomas Bloomston, Mark Bekaii-Saab, Tanios Lesinski, Gregory J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649353/ http://dx.doi.org/10.1186/2051-1426-3-S2-P366 Text en Copyright © 2015 Mace et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Mace, Thomas Shakya, Reena Pitarresi, Jason Loftus, Shannon Swanson, Benjamin Young, Gregory Zhong, Xioling Zimmers, Teresa Ostrowski, Michael Ludwig, Thomas Bloomston, Mark Bekaii-Saab, Tanios Lesinski, Gregory Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| title | Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| title_full | Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| title_fullStr | Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| title_full_unstemmed | Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| title_short | Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| title_sort | anti-il-6 and pd-l1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649353/ http://dx.doi.org/10.1186/2051-1426-3-S2-P366 |
| work_keys_str_mv | AT macethomas antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT shakyareena antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT pitarresijason antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT loftusshannon antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT swansonbenjamin antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT younggregory antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT zhongxioling antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT zimmersteresa antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT ostrowskimichael antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT ludwigthomas antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT bloomstonmark antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT bekaiisaabtanios antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer AT lesinskigregory antiil6andpdl1antibodycombinationtherapyreducestumorprogressioninmurinemodelsofpancreaticcancer |